Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2017-08-25FDA Approved: GLIMEPIRIDE — Supplemental Application (Micro Labs Limited)
The FDA approved a supplemental application for glimepiride submitted by Micro Labs Limited.
-
CLINICAL_TRIALS research · 2017-08-24Clinical Trial Update: Families Preventing Diabetes Together [NA]
This clinical trial update reports the completion of the Families Preventing Diabetes Together study sponsored by the University of Minnesot…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Corneal Endothelial Cell Changes After Phacoemulsification in Patients With Type 2 Diabetes Mellitus
This clinical trial update reports corneal endothelial cell changes after phacoemulsification cataract surgery in patients with type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus [NA]
A completed clinical trial evaluated EPA supplementation on vascular inflammation and PON2 gene expression in patients with Type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Individualized Lifestyle Intervention in Subjects With Prediabetes [NA]
This completed clinical trial investigated an individualized lifestyle intervention in people with prediabetes to assess its impact on progr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: DPP-4 Inhibition, Incretins and Islet Function [Phase 4]
A Phase 4 study from Lund University evaluated the effects of DPP-4 inhibition on incretins and pancreatic islet function in people with typ…
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Renal Impairment Study With ASP1941 [Phase 1]
Phase 1 renal impairment study of ASP1941 has completed in adults with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin [Phase 1]
A Phase 1 trial investigating the mechanism of action of ipragliflozin in Type 2 diabetes has completed.
-
CLINICAL_TRIALS research · 2017-08-22Clinical Trial Update: Effect of Viscous Soluble Fibres on Body Weight
An update on a clinical study examining the effect of viscous soluble fibres on body weight in adults with overweight/obesity or type 2 diab…
-
CLINICAL_TRIALS research · 2017-08-22Clinical Trial Update: Primary Care - Continuous Glucose Monitoring
This Clinical Trial Update from the University of Zagreb concerns a study on Type 2 Diabetes Mellitus using Continuous Glucose Monitoring in…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus
Clinical trial update reporting on the safety profile of liraglutide when used under normal conditions in Korean adults with type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Metformin Versus Vildagliptin for Diabetic Hypertensive Patients [Phase 4]
Phase 4 trial comparing metformin and vildagliptin in patients with type 2 diabetes and hypertension, completed to evaluate effects on blood…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Clopidogrel Versus Ticagrelor in Type-2 Diabetes [Phase 4]
A Phase 4 study comparing clopidogrel and ticagrelor in patients with coronary artery disease and type 2 diabetes has completed, with result…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo. [Phase 1]
Phase 1 scintigraphy study to assess gastric emptying in healthy subjects given GSK716155 or placebo; the trial completed and was sponsored …
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus [Phase 1]
This entry notes the completion of a Phase 1 clinical assessment of GSK716155 for type 2 diabetes mellitus.
-
CLINICAL_TRIALS research · 2017-08-17Clinical Trial Update: Effect of Holistic Management on the Patients With Type 2 Diabetes [NA]
This clinical trial update concerns a study on holistic management for patients with Type 2 Diabetes, with the study status currently not av…
-
FDA approval · 2017-08-16FDA Approved: GLUCOTROL XL — Supplemental Application (Roerig)
The FDA approved a supplemental application for GLUCOTROL XL (glipizide) submitted by Roerig.
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin [Phase 2]
Phase 2 trial assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK2330672 in adults with Type 2 diabetes mellitus o…
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Randomized Control Trial for Overweight Employees in Worksites [NA]
A completed randomized controlled trial conducted at Indian worksites evaluated lifestyle risk reduction in overweight employees with Type 2…
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: The Effectiveness of Diabetes Self-Management Education Program Based on Behavioural Change Theory [NA]
This clinical trial update assesses the effectiveness of a diabetes self-management education program based on behavioral change theory in a…
-
FDA approval · 2017-08-14FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Metformin Hydrochloride from Granules Pharmaceuticals Inc., updating the regulatory status of th…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration. [Phase 1]
Phase 1 study evaluating the effect of food on pharmacokinetics, safety, and tolerability of two different dose combinations of saxagliptin/…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Adverse Effects of Systemic Hypoglycemia Exposure on Endothelial Function in Humans [NA]
The clinical trial evaluating adverse effects of systemic hypoglycemia exposure on endothelial function in individuals with Type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Diet and Systemic Inflammation [NA]
Trial update reporting completed results from a study on how diet affects systemic inflammation.
-
CLINICAL_TRIALS research · 2017-08-14Clinical Trial Update: Inspiratory Muscle Training on Glycemic Control in Individuals With Type 2 Diabetes [NA]
This clinical trial entry describes a study evaluating whether inspiratory muscle training can improve glycemic control in individuals with …